World's Best Scientists 2026 revealed!
CNS Drugs
H-index 41

CNS Drugs

1172-7047

Published by: Springer

https://www.springer.com/journal/40263

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 476 138 144 36

Additional Metrics

Number of Best Scientists*: 275
Documents by Best Scientists*: 210
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 132
SCIMAGO SJR: 1.884
Impact Factor: 7.4

Overview

Top Research Topics at CNS Drugs?

CNS Drugs facilitates discussions on Psychopharmacology, Psychiatry, Pharmacotherapy, Neurology and Internal medicine. CNS Drugs covers Psychopharmacology research under the subject of Pharmacology. It focuses on different Pharmacology studies like Pharmacokinetics and Drug.

Most of the Psychiatry studies addressed also intersect with Clinical psychology. It explores topics in Pharmacotherapy which can be helpful for research in disciplines like Anesthesia, Clinical trial, Adverse effect, Intensive care medicine and Pediatrics. The majority of Anesthesia studies presented zero in on Migraine.

The studies in Neurology featured incorporate elements of Surgery, MEDLINE, Stroke, Disease and Multiple sclerosis. While work presented in it provided substantial information on Internal medicine, it also covered topics in Placebo, Oncology and Endocrinology. Research in Olanzapine and the interrelating topic of Quetiapine and Atypical antipsychotic were among the subjects of interest in the Risperidone studies discussed in the journal.

  • Psychopharmacology (29.85%)
  • Psychiatry (28.76%)
  • Pharmacotherapy (26.91%)

What are the most cited papers published in the journal?

  • Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review. (1214 citations)
  • Tyrosine kinase inhibitors (1134 citations)
  • Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. (511 citations)

Research areas of the most cited articles at CNS Drugs:

Psychiatry, Psychopharmacology, Internal medicine, Pharmacology and Neuroscience are the main subjects of interest in the most cited publications. The works on Psychopharmacology tackled in the journal articles bring together disciplines like Anesthesia, Pharmacotherapy and Bioinformatics. Placebo and Endocrinology are some topics wherein Internal medicine research discussed in the most cited papers has an impact.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

The aim of the journal is to expand the discussion of research in Pharmacotherapy, Psychopharmacology, Neurology, Internal medicine and Adverse effect. Pharmacotherapy research in the journal involves the investigation of Antipsychotic studies, all of which are linked to disciplines such as Clozapine. The Psychopharmacology study which was featured in CNS Drugs aims to expound on the research in Psychiatry.

Topics in Neurology were tackled in line with various other fields like Anesthesia, Observational study, Bioinformatics, Disease and Pediatrics. The concepts on Internal medicine presented in the journal can also apply to other research fields, including Multiple sclerosis and Placebo. The journal holds forums on Adverse effect that merges themes from other disciplines such as Gastroenterology and Pharmacokinetics.

The most cited articles from the last journal are:

  • COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. (25 citations)
  • Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. (8 citations)
  • Intranasal Insulin for Alzheimer’s Disease (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in CNS Drugs (based on the number of publications) are:

  • Gillian M. Keating (39 papers) absent at the last edition,
  • Lesley J. Scott (34 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Greg L. Plosker (22 papers) absent at the last edition,
  • David Taylor (17 papers) absent at the last edition,
  • David Coghill (16 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in CNS Drugs (based on the number of publications) are:

  • Abu Dhabi Indian School (160 papers) absent at the last edition,
  • Harvard University (42 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Springer Science+Business Media (41 papers) published 4 papers at the last edition the same number as at the previous edition,
  • University of Toronto (38 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • University of Melbourne (35 papers) published 5 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.71% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 23.46% were posted by at least one author from the top 10 institutions publishing in the journal. Another 16.05% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 8.64% of all publications and 51.85% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Nursing in Psychopharmacology

Despite being an integral part of healthcare, nursing has significantly evolved over the years. A particular area that nursing has embraced is in the study of Psychopharmacology. Psychopharmacology has amped the competency of nurses in managing patients with mental health issues, making them an indispensable part of a healthcare team. The nursing specialties in this research area require additional training, focusing on the therapeutic use, side-effects, interactions, and abuse potential of psychotropic medications. Today, many accredited nursing schools have included Psychopharmacology in their curriculum. These programs guide nursing students to comprehend the biological impacts of these medications and master the skill required to prescribe them effectively. Students can review these training programs in schools like the ones listed under the best nursing schools in Virginia. The inclusion of psychopharmacology in nursing education implies the critical role nurses play in administering psychiatric treatment. It further underlines the increasing collaboration between the field of neuroscience and nursing. As nurses are usually the first point of contact for patients, their understanding of psychopharmacology can foster a more holistic patient management approach, thus translating to better mental health outcomes. It is essential to recognize the fundamental transformation nursing education has undergone and continues to go through, especially concerning emerging research areas. Contributions of nurses in interdisciplinary health fields such as Psychopharmacology serve as an excellent example of such growth. The rise of such specialties within nursing not only empowers nurses but also fills a significant gap in patient care.

Top Publications

  • The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond

    Wolfgang Löscher;Pavel Klein

    (2021)
    191 Citations
  • Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies

    Joost J. Breeksema;Alistair R. Niemeijer;Erwin Krediet;Eric Vermetten

    (2020)
    152 Citations
  • A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

    (2022)
    116 Citations
  • Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications

    Emilio Perucca;Meir Bialer

    (2020)
    115 Citations
  • COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.

    Anthony T Reder;Diego Centonze;Maria L Naylor;Anjali Nagpal

    (2021)
    112 Citations
  • Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.

    Christoph U. Correll;Christoph U. Correll;Edward Kim;Jennifer Kern Sliwa;Wayne Hamm

    (2021)
    107 Citations
  • Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

    Robert T Naismith;Annette Wundes;Tjalf Ziemssen;Elzbieta Jasinska

    (2020)
    106 Citations
  • Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

    Ioline D. Henter;Lawrence T. Park;Carlos A. Zarate

    (2021)
    99 Citations
  • Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score

    (2022)
    95 Citations
  • Overview of Current Drug Delivery Methods Across the Blood–Brain Barrier for the Treatment of Primary Brain Tumors

    Rianne Haumann;Jessica Carvalho Videira;Gertjan J L Kaspers;Dannis G van Vuurden

    (2020)
    95 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but not ready to commit to a full medical degree, several online programs offer flexible pathways. A health information management online degree prepares students to handle vital patient data and support healthcare operations, a growing field with strong job prospects.

Nutrition also plays a critical role in medicine, and an online master’s degree in nutrition offers advanced knowledge for those looking to specialize in dietetics or wellness counseling, often complementing clinical practices.

Technical professions such as diagnostic imaging are essential in modern healthcare. Online options like an online ultrasound tech school provide hands-on training remotely, enabling students to enter this dynamic field quickly and efficiently.

Similarly, an accelerated radiology tech programs online offer fast-tracked education for those looking to become radiologic technologists, vital for diagnostic support in hospitals and clinics.

Best Scientists Contributing to This Journal

Recently Published Articles